|Full Name||UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4|
|Product Description||Rabbit Polyclonal antibody to B3GALT4 (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4)|
|Background||This gene is a member of the beta-1,3-galactosyltransferase (beta3GalT) gene family. This family encodes type II membrane-bound glycoproteins with diverse enzymatic functions using different donor substrates (UDP-galactose and UDP-N-acetylglucosamine) and different acceptor sugars (N-acetylglucosamine, galactose, N-acetylgalactosamine). The beta3GalT genes are distantly related to the Drosophila Brainiac gene and have the protein coding sequence contained in a single exon. The beta3GalT proteins also contain conserved sequences not found in the beta4GalT or alpha3GalT proteins. The carbohydrate chains synthesized by these enzymes are designated as type 1, whereas beta4GalT enzymes synthesize type 2 carbohydrate chains. The ratio of type 1:type 2 chains changes during embryogenesis. By sequence similarity, the beta3GalT genes fall into at least two groups: beta3GalT4 and 4 other beta3GalT genes (beta3GalT1-3, beta3GalT5). This gene is oriented telomere to centromere in close proximity to the ribosomal protein S18 gene. The functionality of the encoded protein is limited to ganglioseries glycolipid biosynthesis. [provided by RefSeq]|
|Synonyms||BETA3GALT4 antibody, GALT2 antibody, GALT4 antibody, B3GALT4 antibody, b3Gal-T4 antibody, gal-T2 antibody, ganglioside galactosyltransferase antibody, "beta-1,3-GalTase 4 antibody", "UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase antibody", "beta-1,3-galactosyltransferase 4 antibody", beta-3-galactosyltransferase 4 antibody, "UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 antibody"|
|Cellular Localization||Golgi apparatus membrane |
|Immunogen||Recombinant protein encompassing a sequence within the center region of human B3GALT4. The exact sequence is proprietary.|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Dog, Rhesus Monkey, Bovine|
|Predict Reactivity Note||Dog (81%), Rhesus Monkey (98%), Bovine (83%)|